Market Overview

InterMune Spikes On Report It Hired Goldman Sachs; Mulls Multiple Bids

Related ITMN
What You Need to Know About the Roche-InterMune Deal
Markets Reverse Early Morning Losses; Still Lower On The Day

InterMune (NASDAQ: ITMN) shares spiked nearly 20 percent after it was reported that it hired Goldman Sachs to evaluate multiple acquisition bids.

The news, reported by Bloomberg, said InterMune is also working with investment bank Centerview Partners on the deal.

Betaville, a financial blog, said Monday that InterMune has begun working with bankers from Evercore Partner to evaluate deals. The blog reported rumors in both April and July that a deal could be in the works.

Reuters and CNBC reported similar rumors in March.

Bloomberg said Monday that InterMune has offers from Sanofi SA as well as Roche Holding Ltd., GlaxoSmithKline and Actelion.

InterMune traded recently at $50.47, up 10.9 percent.

Posted-In: News Rumors M&A Hot Movers


Related Articles (ITMN)

View Comments and Join the Discussion!

Partner Center